ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 187,65
0,00%
Dow Jones
39 387,76
0,85%
DAX
18 686,60
1,07%
Brent Oil
84,245
0,35%
Bitcoin
62 774,53
-0,44%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Standard BioTools Inc (LAB)

  7. Standard BioTools Inc (LAB) Actualités

LAB Standard BioTools Inc

2,41
0,17 (7,59%)
10 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Standard BioTools Inc LAB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,17 7,59% 2,41 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,24 2,24 2,525 2,41 2,24
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/5/202422:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:31EDGAR2Form 8-K - Current report
08/5/202422:01GLOBEStandard BioTools Reports First Quarter 2024 Financial..
25/4/202414:01GLOBEStandard BioTools Announces Operational Restructuring Plan..
25/4/202414:00GLOBEStandard BioTools Announces Conference Call and Webcast for..
08/4/202414:00GLOBEStandard BioTools Introduces New High-Throughput Multiplexed..
03/4/202422:01GLOBEStandard BioTools Announces Multi-Year Strategic Engagement..
18/3/202413:12GLOBEStandard BioTools Announces Exchange of All Outstanding..
07/3/202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:05EDGAR2Form 8-K - Current report
28/2/202422:01GLOBEStandard BioTools Reports Fourth Quarter and Full Year 2023..
26/2/202422:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/2/202414:00GLOBEStandard BioTools and Next Gen Diagnostics Announce..
22/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:05GLOBEStandard BioTools to Participate in Upcoming Investor..
14/2/202421:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:30GLOBEStandard BioTools Announces Conference Call and Webcast for..
08/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
07/2/202414:30GLOBEStandard BioTools and Navignostics Announce Collaboration..
02/2/202422:49EDGAR2Form S-3/A - Registration statement under Securities Act of..
19/1/202423:07EDGAR2Form S-3 - Registration statement under Securities Act of..
19/1/202423:05EDGAR2Form S-3 - Registration statement under Securities Act of..
19/1/202423:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/1/202422:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/1/202422:33EDGAR2Form 8-K/A - Current report: [Amend]
12/1/202420:04EDGAR2Form SC 13D/A - General statement of acquisition of..
10/1/202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/1/202400:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/1/202400:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/1/202423:13EDGAR2Form SC 13D/A - General statement of acquisition of..
08/1/202423:00EDGAR2Form SC 13D/A - General statement of acquisition of..
08/1/202414:39EDGAR2Form 8-K - Current report
08/1/202414:30GLOBEStandard BioTools Announces Preliminary Fourth Quarter and..
05/1/202414:53EDGAR2Form 8-K - Current report
05/1/202414:46GLOBEStandard BioTools Completes Merger with SomaLogic, Creating..
05/1/202404:23GLOBEStandard BioTools Stockholders Approve Merger with SomaLogic
05/1/202403:44PRNUSSomaLogic Stockholders Vote to Approve Standard BioTools..
29/12/202323:26EDGAR2Form 425 - Prospectuses and communications, business..
29/12/202323:25EDGAR2Form 8-K - Current report
29/12/202323:04GLOBEGlass Lewis Recommends Standard BioTools Stockholders Vote..
28/12/202322:16PRNUSDr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to..
26/12/202321:59PRNUSSomaLogic Issues Statement Correcting Madryn Asset..
23/12/202300:57GLOBEISS Recommends Standard BioTools Stockholders Vote “FOR” All..
21/12/202314:00GLOBESomaLogic Issues Letter to Stockholders Reiterating..
20/12/202315:00GLOBESkye Fund III Issues Letter Regarding Opposition to..

Dernières Valeurs Consultées

NASDAQ
LAB
Standard BioTools
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés